QualityStocksNewsBreaks Archives - Page 2 of 1483

FridayJan 09, 2026 12:50 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Reaches Enrollment Milestone in Phase 3 FLASH2 Trial for HyBryte(TM)

Soligenix (NASDAQ: SNGX) is a New Jersey-based biopharmaceutical company focused on developing products to treat rare diseases where there is an unmet medical need. The company recently received updated analysis from Zacks Small-Cap Research following its announcement that milestone enrollment had been reached in the ongoing confirmatory Phase 3 FLASH2 trial of HyBryte(TM). The study focuses on the treatment of cutaneous T-cell lymphoma, with the overall blinded response rate standing at 48% for patients who have completed treatment. “In the Nov. 20, 2025, research report published by Zacks Small-Cap Research, expert analysis indicated strong conviction about the 50-patient enrollment milestone and…

FridayJan 09, 2026 12:25 pm

QualityStocksNewsBreaks – FDA Clearance for HeartBeam Inc. (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup

HeartBeam (NASDAQ: BEAT) was among the medical device companies highlighted in a Jan. 8 report by Modern Healthcare by Lauren Dubinsky that outlined FDA clearances and approvals across the medical device sector. HeartBeam's 12-lead electrocardiogram synthesis software was cleared Dec. 8 to assess arrhythmias by converting heart signal data captured from 3 dimensions using the company’s portable, non-invasive recorder into a standard 12-lead ECG format suitable for remote clinical review. HeartBeam recently reinforced its technology leadership with recognition as a Global IP and Technology Leader in Portable Cardiac Diagnostics, ranking second worldwide and trailing only GE Healthcare, in 12-lead ECG innovation among 243 companies evaluated in PatentVest’s…

FridayJan 09, 2026 12:20 pm

QualityStocksNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Advances Nanoparticle Drug Delivery, Prepares First-in-Human Study of IV Everolimus

Oncotelic Therapeutics (OTCQB: OTLC) is positioned at the heart of the evolving landscape of pharmaceutical innovation, applying ultra-small carrier technologies to elevate existing cancer therapies. “The company is pioneering how nanotechnology can enhance bioavailability, precision targeting and therapeutic performance of anticancer compounds,” reads a recent article. “The advantages of nanoparticle delivery in pharma are significant… The contemporary view holds that nanocarrier-enabled formulations may be as transformative for drug delivery as the advent of monoclonal antibodies was for biologics… Into this context, Oncotelic Therapeutics, which in its most recent news has advanced nanoparticle-based delivery strategies through its joint venture entity, involving its…

FridayJan 09, 2026 12:12 pm

QualityStocksNewsBreaks – OptimumBank Holdings, Inc. (NYSE American: OPHC) Launches Q1 2026 Owner-Occupied Commercial Real Estate Financing Promotion

OptimumBank Holdings (NYSE American: OPHC) announced the launch of a limited-time owner-occupied commercial real estate financing promotion for the first quarter of 2026, offering qualified borrowers up to 80 percent loan-to-value at an interest rate of SOFR plus 2.67 percent with a one-quarter point origination fee. The promotion is aimed at supporting growing businesses seeking competitive financing solutions while reinforcing the bank’s relationship-driven lending model and local decision-making approach, with applications required to be completed and submitted by March 31, 2026. To view the full press release, visit https://ibn.fm/8h9kh About OptimumBank OptimumBank was founded in 2000 in Ft. Lauderdale, Florida. Our customers found a bank that…

FridayJan 09, 2026 9:55 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Highlights Strategic New York and Philadelphia Edge Network Deployment With SanQtum AI Platform

Datavault AI (NASDAQ: DVLT) highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure’s SanQtum AI platform, a GPU-powered, zero-trust edge infrastructure designed to enable instant data monetization with national security-grade cybersecurity. The deployment integrates SanQtum AI Enterprise Units directly into Datavault AI’s patented Information Data Exchange, DataScore, and Datavalue AI agents, allowing real-time data scoring, tokenization at birth, and enterprise-grade AI processing without reliance on public cloud infrastructure. Company estimates indicate an addressable market exceeding $2 billion in each metropolitan region, driven by strong demand across insurance and financial services applications including real-time data tokenization, AI workloads, secure verification, and private micro-exchanges, positioning Datavault AI for significant recurring revenue…

ThursdayJan 08, 2026 10:57 am

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Demonstrates 100% Interception Success of DefendAir System Against Advanced Hostile Drones

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company specializing in smart, autonomous solutions for manned and unmanned aerial systems, announced that its DefendAir Counter-Unmanned Aerial System has achieved 100% interception success in live field demonstrations against two of the most challenging hostile drone threats: FPV kamikaze attack drones and DJI FlyCart heavy-lift smuggling drones. Conducted under controlled real-world conditions, the demonstrations validated DefendAir’s patented, net-based, non-explosive interception technology, building on prior trials that also recorded perfect interception rates against fast-incoming multirotor threats and reinforcing the system’s applicability for military forces, border security and critical infrastructure protection. To view the full press release, visit https://ibn.fm/SEup5 About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense…

ThursdayJan 08, 2026 9:20 am

QualityStocksNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Study Shows Nu.Q Vet Feline Test Accurately Detects Lymphoma in Cats

VolitionRx (NYSE American: VNRX), a multinational epigenetics company, announced results from a clinical study demonstrating high accuracy of its Nu.Q Vet Feline assay in detecting lymphoma in cats, the most common cancer in the species. At 100% specificity, meaning no false positives, the blood-based assay detected more than 80% of feline lymphomas, supporting development of what the company expects to be the world’s first simple and affordable liquid biopsy test for feline cancer. The company stated that feline cancer has historically been difficult to diagnose early, often requiring invasive biopsies or costly imaging after symptoms have progressed, and noted that…

ThursdayJan 08, 2026 9:10 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Sets Feb. 21, 2026, Distribution Date for Previously Announced Warrant Dividend

Datavault AI (NASDAQ: DVLT), a leader in data monetization, credentialing and digital engagement technologies, announced that its board of directors has set Feb. 21, 2026, or such other date as determined by the board, as the distribution date for its previously announced dividend of warrants to purchase shares of common stock for eligible record equity holders. The previously announced record date remains Jan. 7, 2026, with the warrants to be distributed on the basis of one warrant for each 60 shares of common stock held, or shares underlying other Datavault AI equity securities, subject to applicable contractual terms. To view…

ThursdayJan 08, 2026 9:05 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands IBM Collaboration to Deliver Enterprise AI at the Edge in New York and Philadelphia

Datavault AI (NASDAQ: DVLT), a leader in instant data monetization and enterprise digital twins, announced it will deliver enterprise-grade artificial intelligence performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform operated by Available Infrastructure. The deployment will utilize IBM watsonx AI products running within SanQtum AI’s zero-trust, micro edge data center network to enable cybersecure data storage and compute, real-time data scoring, tokenization, credentialing, and ultra-low-latency processing across two of the most data-dense metropolitan regions in the United States, supporting enterprise AI workloads without reliance on public cloud infrastructure.…

ThursdayJan 08, 2026 9:00 am

QualityStocksNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK

Lixte Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical manufacturer GSK on an ongoing clinical trial evaluating its proprietary compound LB-100 in combination with GSK’s Dostarlimab for the treatment of ovarian clear cell cancer. The trial, initiated in January 2024 and led by Amir Jazaeri, MD, at MD Anderson, has added a second site at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University under the direction of Emily M. Hinchcliff, MD, MPH, and is expected to double enrollment to 42 patients following completion of its…

Site Search

Company Search

Category: QualityStocksNewsBreaks